BCG 020
Alternative Names: BCG-020Latest Information Update: 26 Jun 2024
At a glance
- Originator Beijing Biocytogen
- Class Antineoplastics; Bispecific antibodies; Immunotherapies
- Mechanism of Action CD70 antigen modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours